Your browser doesn't support javascript.
loading
Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants.
Escudero, Adela; Takagi, Masatoshi; Auer, Franziska; Friedrich, Ulrike Anne; Miyamoto, Satoshi; Ogawa, Atsushi; Imai, Kohsuke; Pascual, Barbara; Vela, María; Stepensky, Polina; Yasin, Layal; Elitzur, Sarah; Borkhardt, Arndt; Pérez-Martínez, Antonio; Hauer, Julia.
Affiliation
  • Escudero A; Department of Genetics, Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
  • Takagi M; Translational Research Group in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, Institute for Health Research (IdiPAZ), La Paz University Hospital, Madrid, Spain.
  • Auer F; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. m.takagi.ped@tmd.ac.jp.
  • Friedrich UA; Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, School of Medicine, Technical University of Munich, Munich, Germany.
  • Miyamoto S; Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital "Carl Gustav Carus", Technical University Dresden (TUD), Dresden, Germany.
  • Ogawa A; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Imai K; Department of Pediatrics, Niigata Cancer Center, Niigata, Japan.
  • Pascual B; Department of Community Pediatrics, Perinatal and Maternal Medicine Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Vela M; Translational Research Group in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, Institute for Health Research (IdiPAZ), La Paz University Hospital, Madrid, Spain.
  • Stepensky P; Translational Research Group in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, Institute for Health Research (IdiPAZ), La Paz University Hospital, Madrid, Spain.
  • Yasin L; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Elitzur S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Borkhardt A; Pediatric Hematology-Oncology, Schneider Children's Medical Center and Sackler Faculty of Medicine, Tel-Aviv university, Tel-Aviv, Israel.
  • Pérez-Martínez A; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Hauer J; Translational Research Group in Pediatric Oncology, Hematopoietic Transplantation & Cell Therapy, Institute for Health Research (IdiPAZ), La Paz University Hospital, Madrid, Spain.
Leukemia ; 36(9): 2338-2342, 2022 09.
Article in En | MEDLINE | ID: mdl-35902733
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia / PAX5 Transcription Factor Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia / PAX5 Transcription Factor Limits: Humans Language: En Year: 2022 Type: Article